Having trouble accessing articles? Reset your cache.

House committee votes to reinstate human germline gene editing ban, calls for study of allowing mitochondrial replacement

The House Appropriations Committee Tuesday voted to reinstate a prohibition on FDA review of applications to conduct research “in which a human embryo is intentionally created or modified to include a heritable genetic modification.” Several Democrats said they reluctantly supported the ban and called for congressional committees to investigate the merits of research on allowing mitochondrial replacement therapy.

The germline editing research ban was first

Read the full 656 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers